1 |
Bertini, R., Bianchi, M., Erroi, A., Villa, P. and Ghezzi, P. (1989). Dexamethasone modulation of in vivo effects of endotoxin, tumor necrosis factor, and interleukin-1 on liver cytochrome P-450, plasma fibrinogen, and serum iron. J. Leukoc. Biol., 46, 254-262
DOI
|
2 |
Cassatella, M.A., Meda, L., Bonora, S., Ceska, M. and Constantin, G. (1993). Interleukin 10 (IL-10) inhibits the release of proinflammatory cytokines from human polymorphonuclear leukocytes. Evidence for an autocrine role of tumor necrosis factor and IL-1 beta in mediating the production of IL-8 triggered by lipopolysaccharide. J. Exp. Med., 78, 2207-2211
|
3 |
Choi, Y.H. and Lee, M.G. (2006). Effects of enzyme inducers and inhibitors on the pharmacokinetics of metformin in rats: involvement of CYP2C11, 2D1 and 3A1/2 for the metabolism of metformin. Br. J. Pharmacol., 149, 424-430
DOI
ScienceOn
|
4 |
Choi, Y.H., Kim, S.G. and Lee, M.G. (2006). Dose-independent pharmacokinetics of metformin in rats: hepatic and gastrointestinal first-pass effects. J. Pharm. Sci., 95, 2543- 2552
DOI
ScienceOn
|
5 |
Churchill, P.C., Bidani, A.K. and Schwartz, M.M. (1987). Renal effects of endotoxin in the male rat. Am. J. Physiol., 253, F244-F250
|
6 |
Hasegawa, T., Nadia, M., Wang, L., Haghgoo, S., Nabeshima, T. and Kato, N. (1994b). Influence of endotoxin and lipid A on the renal handling and accumulation of gentamicin in rats. Biol. Pharm. Bull., 17, 1651-1655
DOI
ScienceOn
|
7 |
Hewett, J.A. and Roth, R.A. (1993). Hepatic and extrahepatic pathobiology of bacterial lipopolysaccharides. Pharmacol. Rev., 45, 382-411
|
8 |
Hinshaw, L.B., Brandley, G.M. and Carlson, C.H. (1959), Effect of endotoxin on renal function in the dog. Am. J. Physiol., 196, 1127-1131
|
9 |
Kikeri, D., Pennell, J.P., Hwang, K.H., Jacob, A.I., Richman, A.V. and Bourgoignie, J.J. (1986). Endotoxemic acute renal failure in awake rats. Am. J. Physiol., 250, F1098- F1106
|
10 |
Kim, Y.C., Shim, H.J., Lee, J.H., Kim, S.H., Kwon, J.W., Kim, W.B. and Lee, M.G. (2005a). Effects of enzyme inducers and inhibitors on the pharmacokinetics of intravenous DA- 8159, a new erectogenic, in rats. Biopharm. Drug Dispos., 26, 233-241
DOI
ScienceOn
|
11 |
Kunihara, M., Nagai, J., Murakami, T. and Takano, M. (1998). Renal excretion of rhodamine 123, a P-glycoprotein substrate, in rats with glycerol-induced acute renal failure. J. Pharm. Pharmacol., 50, 1161-1165
DOI
|
12 |
Leclercq, V., Desager, J.P., Horsmans, Y., van Nieuwenhuyze, Y. and Harvengt, C. (1989). Influence of rifampicin, phenobarbital and cimetidine on mixed function monooxygenase in extensive and poor metabolizers of debrisoquine. Int. J. Clin. Pharmacol. Ther. Toxicol., 27, 593-598
|
13 |
Lee, M.G. and Chiou, W.L. (1983). Evaluation of potential causes for the incomplete bioavailability of furosemide: gastric first-pass metabolism. J. Pharmacokinet. Biopharm., 11, 623-640
DOI
|
14 |
Nadai, M., Sekido, T., Matsuda, I., Li, W., Kitaichi, K., Itoh, A., Nabeshima, T. and Hasegawa, T. (1998). Time-dependent effects of Klebsiella pneumoniae endotoxin on hepatic drug-metabolizing enzyme activity in rats. J. Pharm. Pharmacol., 50, 871-879
DOI
|
15 |
Wang, L., Hasegawa, T., Nadai, M., Muraoka, I., Nabeshima, T. and Kato, N. (1993). The effect of lipopolysaccharide on the disposition of xanthines in rats. J. Pharm. Pharmacol., 45, 34-38
DOI
|
16 |
Rietschel, E.T., Kirikae, T., Schade, F.U., Ulmer, A.J., Holst, O., Brade, H., Schmidt, G., Mamat, U., Grimmecke, H.D. and Kusumoto, S. (1993). The chemical structure of bacterial endotoxin in relation to bioactivity. Immunobiology, 187, 169-190
DOI
|
17 |
Sewer, M.B. and Morgan, E.T. (1998). Down-regulation of the expression of three major rat liver cytochrome P450S by endotoxin in vivo occurs independently of nitric oxide production. J. Pharmacol. Exp. Ther., 287, 352-358
|
18 |
Sewer, M.B., Koop, D.R. and Morgan, E.T. (1996). Endotoxemia in rats is associated with induction of the P4504A subfamily and suppression of several other forms of cytochrome P450. Drug Metab. Dispos., 24, 401-407
|
19 |
Wright, K. and Morgan, E.T. (1990). Transcriptional and posttranscriptional suppression of P450IIC11 and P450IIC12 by inflammation. FEBS Lett., 271, 59-61
DOI
ScienceOn
|
20 |
Crawford, E.K., Ensor, J.E., Kalvakolanu, I. and Hasday, J.D. (1993). The role of 3' poly(A) tail metabolism in tumor necrosis factor-alpha regulation. J. Biol. Chem., 272, 21120-21127
DOI
ScienceOn
|
21 |
Evans, T.J., Strivens, E., Carpenter, A. and Cohen, J. (1993). Differences in cytokine response and induction of nitric oxide synthase in endotoxin-resistant and endotoxin-sensitive mice after intravenous gram-negative infection. J. Immunol., 150, 5033-5040
|
22 |
Roe, A.L., Warren, G., Hou, G., Howard, G., Shedlofsky, S.I. and Blouin, R.A. (1998). The effect of high dose endotoxin on CYP3A2 expression in the rat. Pharm. Res., 15, 1603-1608
DOI
ScienceOn
|
23 |
Kim, Y.C., Yoo, M. and Lee, M.G. (2005b). DA-8159, Erectogenic. Drugs Future, 30, 678,682
DOI
|
24 |
Morgan, E.T. (1989). Suppression of constitutive cytochrome P-450 gene expression in livers of rats undergoing an acute phase response to endotoxin. Mol. Pharmacol., 36, 699-707
|
25 |
Ogawa, K., Takagi, K. and Satake, T. (1989). Mechanism of xanthine-induced relaxation of guinea-pig isolated trachealis muscle. Br. J. Pharmacol., 97, 542-546
DOI
ScienceOn
|
26 |
Shi, J., Montay, G. and Bhargava, V.O. (2005). Clinical pharmacokinetics of telithromycin, the first ketolide antibacteantibacterial. Clin. Pharmacokinet., 44, 915-934
DOI
ScienceOn
|
27 |
Gorodischer, F., Krasner, J., McDevitt, J.J., Nolan, J.P. and Yaffe, S.J. (1976). Hepatic microsomal drug metabolism after administration of endotoxin in rats. Biochem. Pharmacol., 25, 351-353
DOI
ScienceOn
|
28 |
Lee, J.H. and Lee, M.G. (2007b). Dose-dependent pharmacokinetics of telithromycin after intravenous and oral administration to rats: contribution of intestinal first-pass effect to low bioavailability. J. Pharm. Pharm. Sci., 10, 37-50
|
29 |
Minors, J.O. and McKinnon, R.A. (2000). CYP1A. In Metabolic Drug Interactions. (Levy, R.H., Thummel, K.E., Trager, W.F., Hansten, P.D. and Eichelbaum, M. Eds.) A Wolters Kluwer Company, Philadelphia, PA, USA: Lippincott Williams & Wilkins, pp. 61-74
|
30 |
Morgan, E.T. (1993). Down-regulation of multiple cytochrome P450 gene products by inflammatory mediators in vivo. Independence from the hypothalamo-pituitary axis. Biochem. Pharmacol., 45, 415-419
DOI
ScienceOn
|
31 |
Westphal, O., Jann, K. and Himmelspach, K. (1983). Chemistry and immunochemistry of bacterial lipopolysaccharides as cell wall antigens and endotoxins. Prog. Allergy, 33, 9- 39
|
32 |
Hasegawa, T., Nadai, M., Wang, L., Takayama, Y., Kato, K., Nabeshima, T. and Kato, K. (1994a). Renal excretion of famotidine and role of adenosine in renal failure induced by bacterial lipopolysccharide in rats. Drug Metab. Dispos., 22, 8-13
|
33 |
Ji, H.Y., Lee, H.W. and Kim, H.H. (2004). Role of human cytochrome P450 3A4 in the metabolism of DA-8159, a new erectogenic. Xenobiotica, 34, 973-992
DOI
ScienceOn
|
34 |
Miyamoto, K., Koshiura, R., Hasegawa, T. and Kato, N. (1984). Antitumor activity of Klebsiella 03 lipopolysaccharide in mice. Jpn. J. Pharmacol., 36, 51-57
DOI
|
35 |
Kido, N., Ohta, M., Ito, H., Naito, S., Nagase, F., Nakashima, I. and Kato, N. (1985). Potent adjuvant action of lipopolysaccharides possessing the O-specific polysaccharide moieties consisting of mannans in antibody response against protein antigen. Cell. Immunol., 91, 52-59
DOI
|
36 |
Matsunaga, Y., Miyazaki, H., Oh-e, Y., Nambu, K., Furkawa, H., Yoshida, K. and Hashimoto, M. (1991). Disposition and metabolism of TEX>$^{14}C$-sparfloxacn in the rat. Arzneim-Forsch/ Drug Res., 41, 747-759
|
37 |
Mitruka, B.M. and Rawnsley, H.M. (1981). Clinical Biomedical and Hematological Reference Values in Normal Experimental Animals and Normal Humans, 2nd ed. Masson Publishing USA Inc., New York. NY
|
38 |
Nadai, M., Zhao, Y.L., Wang, L., Nishio, Y., Takagi, K., Kitaichi, K., Takagi, K., Yshizumi, H. and Hasegawa, T. (2001). Endotoxin impairs biliary transport of sparfloxacin and its gucuronide in rats. Eur. J. Pharm., 432, 99-105
DOI
ScienceOn
|
39 |
Yang, K.H., Lee, J.H. and Lee, M.G. (2008). Effects of CYP inducers and inhibitors on the pharmacokinetics of intravenous theophylline in rats: involvement of CYP1A1/2 in the formation of 1,3-DMU. J. Pharm. Pharmcol., (in press)
|
40 |
Cheng, PY., Wang, M. and Morgan, E.T. (2003). Rapid transcriptional suppression of rat cytochrome P450 genes by endotoxin treatment and its inhibition by curcumin. J. Pharmacol. Exp. Ther., 307, 1205-1212
DOI
ScienceOn
|
41 |
Morgan, E.T., Li-Masters, T. and Cheng, P.Y. (2002). Mechanisms of cytochrome P450 regulation by inflammatory mediators. Toxicology, 181-182, 207-210
|
42 |
Sachdeva, K., Yan, B. and Chichester, C.O. (2003). Lipopolysaccharide and cecal ligation/puncture differentially affect the subcellular distribution of the pregnane X receptor but consistently cause suppression of its target genes CYP3A. Shock, 19, 469-474
DOI
ScienceOn
|
43 |
Williams, J.F., Lowitt, S. and Szentivanyi, A. (1979). Effect of phenobarbital and 3-methylcholanthrene pretreatment on the plasma half-life and urinary excretion profile of theophylline and its metabolites in rats. Biochem. Pharmacol., 8, 2935-2940
|
44 |
Lewis, D.F.V. (1996). Chapter 4. P450. Substrate specificity and metabolism. In Cytochromes P450, Structure, Function and Mechanism. (Lewis, D.F.V. Ed.) 2nd edn. Bristol, PA, USA: Taylor & Francis, p. 123
|
45 |
Nadai, M., Hasagawa, T., Wang, L., Haghgoo, S., Nabeshima, T. and Kato, N. (1995). Time-dependent changes in the pharmacokinetics and renal excretion of xanthine derivative enprofylline induced by bacterial endotoxin in rats. Biol. Pharm. Bull., 18, 1089-1093
DOI
|
46 |
Choi, Y.H., Lee, I. and Lee, M.G. (2007b). Effects of water deprivation on the pharmacokinetics of metformin in rats. Biopharm. Drug Dispos., 28, 373-383
DOI
ScienceOn
|
47 |
Ferrari, L., Peng, N., Halpert, J.R. and Morgan, E.T. (2001). Role of nitric oxide in down-regulation of CYP2B1 protein, but not RNA, in primary cultures of rat hepatocytes. Mol. Pharmacol., 60, 209-216
DOI
|
48 |
Akiyama, H., Abe, Y., Kusumoto, N. and Odomi, M. (1995). Pharmacokinetics of grepafloxacn (II): absorption, distribution and excretion after oral administratio of []-grepafloxacin in rats. Chemotherapy, 43, 107-124
|
49 |
Kushner, I. (1982). The phenomenon of the acute phase response. Ann. N. Y. Acad. Sci., 389, 39-48
DOI
|
50 |
Davies, B. and Morris, T. (1993). Physiological parameters in laboratory animals and humans. Pharm. Res., 10, 1093- 1095
DOI
|
51 |
Monshouwer, M., McLellan, R.A., Delaporte, E., Witkamp, R.F., van Miert, A.S.J.P.A.M. and Renton, K.W. (1996). Differential effect of pentoxifylline on lipopolysaccharideinduced downregulation of cytochrome P450. Biochem. Pharmacol., 52, 1195-1200
DOI
ScienceOn
|
52 |
Szakacs, T., Veres, Z. and Vereczkey, L. (2001). Effect of phenobarbital and spironolactone treatment on the oxidative metabolism of antipyrine by rat liver microsomes. Pol. J. Pharmacol., 53, 11-19
|
53 |
Yang, K.H., Jung, Y.S., Lee, D.Y., Lee, J.H., Kim, Y.C. and Lee, M.G. (2007). Time-dependent effects of Klebsiella pneumoniae endotoxin (KPLPS) on the pharmacokinetics of theophylline in rats; return of the parameters in 96-h KPLPS rats to the control levels. Proceedings of the Convention of the Pharmaceutical Society of Korea, Hotel- Seoul Kyoyuk Munhwa Hoekwan, Nov. 7-8, 2007, Abstract p. 419
|
54 |
Haghgoo, S., Hasegawa, T., Nadai, M., Wang, L., Nabeshima, T. and Kato, N. (1995). Effect of a bacterial lipopolysaccharide on biliary excretion of a -lactam antibiotic, cefoperazone, in rats. Antimicrob. Agents Chemother., 39, 2258-2261
DOI
ScienceOn
|
55 |
Lee, J.H., Cho, Y.K. and Lee, M.G. (2007a). Time-dependent effects of Klebsiella pneumoniae endotoxin (KPLPS) on telithromycin pharmacokinetics in rats; return of the parameters in 96-hour KPLPS to the control levels. Proceedings of the Convention of the Pharmaceutical Society of Korea, Hotel-Seoul Kyoyuk Munhwa Hoekwan, Nov. 7-8, 2007, Abstract p. 414
|
56 |
Miyamoto, K., Takagi, K., Sakai, R., Wakusawa, S., koshiura, R., Nadai, M., Apichartpichean, R. and Hasegawa, T. (1989). Correlation between hydrophobicity of N-alkylxanthine derivatives and their biological activities on guineapig isolated tracheal smooth muscle. J. Pharm. Pharmacol., 41, 844-847
DOI
|
57 |
Ueyama, J., Nadai, M., Kanazawa, H., Iwase, M., Nakayama, H., Hashimoto, K., Yokoi, T., Baba, K., Takagi, K., Takagi, K. and Hasegawa, T. (2005). Endotoxin from various gram-negative bacteria has differential effects on function of hepatic cytochrome P450 and drug transporters. Eur. J. Pharmacol., 510, 127-134
DOI
ScienceOn
|
58 |
Levy, R.H., Thummel, K.E., Trager, W.F., Hansten, P.D. and Eichelbaum, M. Metabolic Drug Interactions. Philadelphia, BA, USA: Lippincott Williams & Wilkins, a Wolters Kluwer Company, 2000
|
59 |
Nadai, M., Hasegawa, T., Kato, K., Wang, L., Nabeshima, T. and Kato, N. (1993a). The disposition and renal handling of enprofylline in endotoxemic rats by bacterial lipopolysaccharide (LPS). Drug Metab. Dispos., 21, 611-616
|
60 |
Wilkinson, G.R. and Shand, D.G. (1975). A physiological approach to hepatic drug clearance. Clin. Pharmacol. Ther., 18, 377-390
DOI
|
61 |
Nadai, M., Hasegawa, T., Kato, K., Wang, L., Nabeshima, T. and Kato, N. (1993c). Alterations in pharmacokinetics and protein binding behavior of cefazoiln in endotoxemic rats. Antimicrob. Agents Chemother., 37, 1781-1785
DOI
ScienceOn
|
62 |
Lee, J.H., Kim, Y.C., Kwon, J.W., Kim, W.B. and Lee, M.G. (2007b). Effects of bacterial lipopolysaccharide on the pharmacokinetics of DA-8159, a new erectogenic in rats. Res. Commun. Mol. Pathol. Pharmacol., (in press)
|
63 |
Bae, S.K., Lee, S.J., Kwon, J.W., Kim, W.B., Lee, I. and Lee, M.G. (2004). Effects of bacterial lipopolysaccharide on the pharmacokinetics of DA-7867, a new oxazolidone, in rats. J. Pharm. Sci., 93, 2364-2373
DOI
ScienceOn
|
64 |
Choi, Y.H., Lee, I. and Lee, M.G. (2007a). Effects of bacterial lipopolysaccharide on the pharmacokinetics of metformin in rats. Int. J. Pharm., 337, 194-201
DOI
ScienceOn
|
65 |
Hasegawa, T., Ohta, M., Kido, N., Kato, N., Miyamoto, K. and Koshiura, R. (1985). Comparative studies on antitumor activity of Klebsiella O3 lipopolysaccharide and its polysaccharide fraction in mice. Jpn. J. Pharmacol., 38, 355-360
DOI
|
66 |
Llewelyn, M. and Cohen, J. (2001). New insights into the pathogenesis and therapy of sepsis and septic shock. Curr. Clin. Top. Infect. Dis., 21, 148-171
|
67 |
Ohta, M., Nakashima, I. and Kato, N. (1982). Adjuvant action of bacterial lipopolysaccharide in induction of delayed-type hypersensitivity to protein antigens. II. Relationships of intensity of the action to that of other immunological activities. Immunobiology., 163, 460-469
DOI
|
68 |
Ortiz de Montellano, P.R. (2005). Cytochrome P450. Structure, Mechanism, and Biochemistry. 3rd edn. New York, USA: Kluwer Academic/Plenum Publishers
|
69 |
Ando, K., Nishio, Y., Ito, K., Nakao, A., Wang, L., Zhao, Y.L., Kitaichi, K., Takagi, K. and Hasegawa, T. (2001). Effect of endotoxin on P-glycoproein-mediated biliary and renal excretion of rhodamine-123 in rats. Antimicrob. Agents Chemother., 45, 3462-3467
DOI
ScienceOn
|
70 |
Kato, N., Ohta, M., Kido, N., Naito, S., Nakashima, I., Nagase, F. and Yokochi, T. (1985). Strong adjuvanticity of bacterial lipopolysaccharides possessing the homopolysaccharides consisting of mannose as the O-specific polysaccharide chains. Med. Microbiol. Immunol., 174, 1-14
|
71 |
Nadai, M., Kato, M., Yasui, K., Kimura, M., Zhao, Y.L., Ueyama, J., Tsumekawa, Y., Yoshizumi, H. and Kasegawa, Y. (2007). Lack of effect of acyclovir on metabolism of theophylline and expression of hepatic cytochrome P450 1A2 in rats. Biol. Pharm. Bull., 30, 562-568
DOI
ScienceOn
|
72 |
Remick, D., Manohar, P., Bolgos, G., Rodriguez, J., Moldawer, L. and Wollenberg, G. (1995). Blockade of tumor necrosis factor reduces lipopolysaccharide lethality, but not the lethality of cecal ligation and puncture. Shock, 4, 89-95
DOI
ScienceOn
|
73 |
Scheen, A.J. (1996). Clinical pharmacokinetics of metformin. Clin. Pharmacokinet., 30, 359-371
DOI
ScienceOn
|
74 |
Engel, G., Hofmann, U., Heidemann, H., Cosme, J. and Eichelbaum, M. (1996). Antipyrine as a probe for human oxidative drug metabolism: identification of the cytochrome P450 enzymes catalyzing 4-hydroxyantipyrine, 3-hydroxymethylantipyrine, and norantipyrine formation. Clin. Pharmacol. Ther., 59, 613-623
DOI
|
75 |
Lee, J.H. and Lee, M.G. (2007a). Effects of acute renal failure on the pharmacokinetics of telithromycin in rats: negligible effects of increase in CYP3A1 on the metabolism of telithromycin. Biopharm. Drug Dispos., 28, 157-166
DOI
ScienceOn
|
76 |
Cavanagh, D., Rao, P.S., Sutton, D.M., Bhagat, B.D. and Bachmann, F. (1970). Pathophysiology of endotoxin shock in the primate. Am. J. Obstet. Gynecol., 108, 705-722
DOI
|
77 |
Bae, S.K., Kim, E.J., Kwon, J.W., Kim, W.B., Lee, I. and Lee, M.G. (2005). Excretion and metabolism of DA-7867, a new oxazolidinone, in rats. Biopharm. Drug Dispos., 26, 67-75
DOI
ScienceOn
|
78 |
Kalitsky-Szirtes, J., Shayeganpour, A., Brocks, D.R. and Piquette-Miller, M. (2004). Suppression of drug-metabolizing enzymes and efflux transporters in the intestine of endotoxin-treated rats. Drug Metab. Dispos., 32, 20-27
DOI
ScienceOn
|
79 |
Liu, P., McGuire, G.M., Fisher, M.A., Farhood, A., Smith, C.W. and Jaeschke, H. (1995). Activation of Kupffer cells and neutrophils for reactive oxygen formation is responsible for endotoxin-enhanced liver injury after hepatic ischemia. Shock, 3, 56-62
DOI
ScienceOn
|
80 |
Nadai, M., Hasegawa, T., Kato, K., Wang, L., Nabeshima, T. and Kato. N. (1993b). Influence of a bacterial lipopolysaccharide on the pharmacokinetics of pharmacokinetics of tobramycin in rats. J. Pharm. Pharmacol., 45, 971-974
DOI
|
81 |
Shim, H.J., Kim, Y.C., Park, K.J., Kim, D.S., Kwon, J.W., Kim, W.B. and Lee, M.G. (2003). Pharmacokinetics of DA-8159, a new erectogenic, after intravenous and oral administration to rats: hepatic and intestinal first-pass effects. J. Pharm. Sci., 11, 2185-2195
|
82 |
Freudenberg, M.A., Keppler, D. and Galanos, C. (1986). Requirement for lipopolysaccharide-responsive macrophages in galactosamine-induced sensitization to endotoxin. Infect. Immun., 51, 891-895
|
83 |
Gilbert, R.P. (1960). Mechanisms of the hemodynamic effects of endotoxin. Physiol. Rev., 40, 245-279
DOI
|
84 |
Nadai, M., Hasegawa, T., Wang, L., Haghgoo, S., Okasaka, T., Mabeshima, T. and Kato, N. (1996). Alterations in renal uptake kinetics of the xanthine derivative enprofylline in endotoxaemic mice. J. Pharm. Pharmacol., 48, 744-748
DOI
|